Evaluating the quality of Japanese YouTube videos on breast cancer treatment using PRHISM: comparison by source credibility
Breast Cancer · 2026
DOI: 10.1007/s12282-025-01796-2 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Breast Cancer, 2026. Verfasst von Hiroki Kusama und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Breast Surgery, Tokyo Medical University, 6-7-1 Nishishinjuku, Shinjuku-ku, Tokyo, 160-0023, Japan. kusama.hiroki.8j@tokyo-med.ac.jp. Hauptthemen laut MEDLINE: Breast Neoplasms, Consumer Health Information, Social Media, Video Recording. Die Arbeit nennt 30 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: Breast cancer patients require a wide range of medical information, and an increasing number now use social media as a primary source. However, the quality of such information varies considerably, and its reliability often depends on the source. To address this, Denniss et al. developed PRHISM, a tool designed to evaluate the quality of information on social media platforms. In our previous study, we demonstrated validity of PRHISM. This study evaluated Japanese YouTube videos on breast cancer treatment and examined differences in quality by source type. METHODS: The top 60 videos displayed in order of relevance were selected on YouTube using the search terms "breast cancer," "treatment," and "chemotherapy." Six breast cancer specialists evaluated the informational quality using PRHISM. Based on the National Academy of Medicine, video sources were classified as credible or other sources. The quality of the videos was then compared using PRHISM scores. RESULTS: The overall mean PRHISM score was 60.6 (SD 11.5); 8 videos (13.3%) were rated excellent and 37 (61.7%) good. Videos from credible sources (n = 19) had a significantly higher mean score (70.9, SD 7.67) than those from other sources (n = 41; 55.8, SD 9.79; p = 0.001). The proportion of videos rated as excellent or good was also significantly higher among credible sources (p = 0.023). CONCLUSION: Japanese YouTube videos on breast cancer treatment were generally of relatively high quality. Videos from credible sources received significantly higher evaluations. When patients search for medical information on YouTube, it is advisable that they refer to content provided by recommended and credible sources.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Breast Surgery, Tokyo Medical University, 6-7-1 Nishishinjuku, Shinjuku-ku, Tokyo, 160-0023, Japan. kusama.hiroki.8j@tokyo-med.ac.jp.
- Department of Health Informatics, Kyoto University School of Public Health, Kyoto, Japan.
- Department of Health Data Science, Tokyo Medical University, Tokyo, Japan.
- Department of Breast Surgery, Tokyo Medical University, 6-7-1 Nishishinjuku, Shinjuku-ku, Tokyo, 160-0023, Japan.
- Department of Breast Oncology, Faculty of Medicine, Juntendo University, Tokyo, Japan.
- Department of Breast Surgery, Ozawa Hospital, Kanagawa, Japan.
Zitieren
APA
Kusama, H., Takahashi, Y., Orihara, S., Adachi, K., Ishizuka, Y., Semba, R., Shima, H., Horimoto, Y., Kaise, H., Taguri, M., Inoue, S., Nakayama, T., & Ishikawa, T. (2026). Evaluating the quality of Japanese YouTube videos on breast cancer treatment using PRHISM: comparison by source credibility. Breast Cancer. https://doi.org/10.1007/s12282-025-01796-2
Vancouver
Kusama H, Takahashi Y, Orihara S, Adachi K, Ishizuka Y, Semba R, et al. Evaluating the quality of Japanese YouTube videos on breast cancer treatment using PRHISM: comparison by source credibility. Breast Cancer. 2026. doi:10.1007/s12282-025-01796-2
BibTeX
@article{Kusama2026,
author = {Kusama, Hiroki and Takahashi, Yoshimitsu and Orihara, Shunichiro and Adachi, Kayo and Ishizuka, Yumiko and Semba, Ryoko and Shima, Hidetaka and Horimoto, Yoshiya and Kaise, Hiroshi and Taguri, Masataka and Inoue, Sho and Nakayama, Takeo and Ishikawa, Takashi},
title = {Evaluating the quality of Japanese YouTube videos on breast cancer treatment using PRHISM: comparison by source credibility},
journal = {Breast Cancer},
year = {2026},
doi = {10.1007/s12282-025-01796-2}
}
EUVIMED